WebDisclosure WebDisclosure
Basculer en Français
9473 Companies
185407 Keywords
117765 Articles
99286 Press releases
Headlines Articles Press releases Public Health Vaccines Remove
  1. Home
  2. Companies
  3. Public Health Vaccines
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 03/21/2024 at 13:05, 1 year 8 months ago

    Public Health Vaccines Initiates First Clinical Trial for Marburg Virus Vaccine

    Phase 1 Clinical Trial Marburg Virus Vaccine Public Health Vaccines RVSV Vector Platform Emerging Infectious Diseases
  • BRIEF

    published on 03/21/2024 at 13:05, 1 year 8 months ago

    Public Health Vaccines lance le premier essai clinique pour le vaccin contre le virus de Marburg

    Essai Clinique De Phase 1 Vaccin Contre Le Virus De Marburg Vaccins De Santé Publique Plateforme Vectorielle RVSV Maladies Infectieuses Émergentes
  • PRESS RELEASE

    published on 03/21/2024 at 13:00, 1 year 8 months ago

    Public Health Vaccines Announces Initiation of First Clinical Trial Evaluating Its Marburg Virus Vaccine

    Public Health Vaccines, LLC initiates Phase 1 clinical trial for single-dose vaccine against Marburg virus, with BARDA funding up to $72 million for development. Company aims for global preparedness against infectious diseases
    Phase 1 Clinical Trial Marburg Virus Vaccine Public Health Vaccines LLC BARDA Funding Global Preparedness
    Logo of Public Health Vaccines
Accesswire
  • Published on 12/05/2025 at 02:35, 6 hours 45 minutes ago

    Future Fuels Initates Drill Permitting at Hornby; Marketing Update

  • Published on 12/05/2025 at 02:30, 6 hours 50 minutes ago

    Klondike Gold Announces AGM Results

  • Published on 12/05/2025 at 01:00, 8 hours 20 minutes ago

    BEACN Closes First Tranche of Non-Brokered Private Placement

  • Published on 12/04/2025 at 23:05, 10 hours 15 minutes ago

    BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025

  • Published on 12/04/2025 at 23:00, 10 hours 20 minutes ago

    NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE
EQS Group
  • Published on 12/05/2025 at 09:05, 14 minutes ago

    Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis

  • Published on 12/05/2025 at 09:00, 19 minutes ago

    Original-Research: DEMIRE AG (von NuWays AG): BUY

  • Published on 12/05/2025 at 09:00, 19 minutes ago

    SPECTRIS PLC - Removal

  • Published on 12/05/2025 at 09:00, 19 minutes ago

    Official List Notice

  • Published on 12/05/2025 at 09:00, 19 minutes ago

    Petershill Partners plc - Removal

View all EQS
Les Echos
  • Published on 12/05/2025 at 08:45, 35 minutes ago

    Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie

  • Published on 12/05/2025 at 08:45, 35 minutes ago

    Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry

  • Published on 12/05/2025 at 08:42, 37 minutes ago

    ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025

  • Published on 12/04/2025 at 18:14, 15 hours 5 minutes ago

    Résiliation d'une convention conclue entre actionnaires

  • Published on 12/04/2025 at 18:00, 15 hours 20 minutes ago

    Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2025 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy